Monopar Therapeutics Stock Predictions

Is the Traditional House Obsolete?

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.

Sell

MNPR
Monopar Therapeutics

Last Price:

$32.55

Seasonality Move:

-21.85%

7 Day Trial

ALL ACCESS PASS

$ 7

Pacaso has reserved the Nasdaq ticker PCSO and is offering shares at just $2.80 - but only until May 29.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with Nasdaq

Monopar Therapeutics Stock Forecast

Over the next 52 weeks, Monopar Therapeutics has on average historically risen by 173.4% based on the past 5 years of stock performance.
Monopar Therapeutics has risen higher in 1 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 20%
Is Monopar Therapeutics Stock Undervalued?

The current Monopar Therapeutics [MNPR] share price is $35.25. The Score for MNPR is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Monopar Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Monopar Therapeutics has on average historically risen by 173.4% based on the past 5 years of stock performance.

Monopar Therapeutics Stock Rating

Sell

Monopar Therapeutics (MNPR) is a Sell

Is Monopar Therapeutics overpriced?

Monopar Therapeutics has risen higher in 1 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 20%

Monopar Therapeutics Stock Price History

Is MNPR stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

monopartx.com

52-Week Data

52-Week High:

54.30

52-Week Low:

1.72

Prediction Charts

Market Cap:

215.6M

Price in USD:

35.25

Volume:

12K

Beta:

1.32

Technical Analysis

SMA50:

37.99

SMA100:

36.60

SMA200:

24.16

52-Wk Change:

1021%

Stock Predictions

Is Monopar Therapeutics stock public?

Yes, Monopar Therapeutics is a publicly traded company.
What is the Monopar Therapeutics stock quote today?

The Monopar Therapeutics stock price is 35.25 USD today.
How to buy Monopar Therapeutics stock online?

You can buy Monopar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
May-7	40.70	39.10	40.70	37.81
May-8	40.45	42.37	44.40	40.42
May-9	41.89	39.42	43.85	39.01
May-12	39.68	35.10	40.20	34.45
May-13	35.10	33.82	37.87	33.34
May-14	32.97	37.11	38.87	32.97
May-15	36.21	39.55	40.10	33.70
May-16	40.33	37.16	40.33	35.65
May-19	36.62	36.90	37.57	36.00
May-20	36.38	36.90	38.05	36.11
May-21	35.80	35.56	39.38	35.43
May-22	35.29	35.44	36.05	35.24
May-23	34.02	35.45	36.34	34.02
May-27	35.45	35.25	36.82	35.13

Monopar Therapeutics Earnings

Monopar Therapeutics Earnings Report: Per Share Monopar Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Monopar Therapeutics Forecast Revenue Growth

Monopar Therapeutics Stock Analysis: Historical quarterly revenues per share for Monopar Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.53 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.77 per share, and an increase next year of $0.41 per share.

* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.